Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

85.87 UNCHANGED
Streaming Delayed Price Updated: 11:31 AM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,969,994
Open 86.35
Bid (Size) 85.86 (2)
Ask (Size) 85.88 (2)
Prev. Close 85.87
Today's Range 85.70 - 86.48
52wk Range 61.24 - 86.57
Shares Outstanding N/A
Dividend Yield 1.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Carlsbad, CA – October 8, 2025 – Ionis Pharmaceuticals (NASDAQ:IONS) is currently witnessing a remarkable surge in its stock value, nearing a six-year high. This impressive ascent is largely driven by... 
Via MarketMinute
AstraZeneca's Baxdrostat Shows Meaningful Blood Pressure Control In Patients With Resistant Hypertension
AstraZeneca's Baxdrostat cut 24-hour systolic blood pressure in a Phase 3 trial, showing promise for treatment-resistant hypertension patients. 
Via Benzinga

Performance

YTD
+30.3%
+30.3%
1 Month
+5.3%
+5.3%
3 Month
+22.6%
+22.6%
6 Month
+32.2%
+32.2%
1 Year
+11.7%
+11.7%

More News

Read More
Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension
From AstraZeneca
Via Business Wire
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
Via Stocktwits
Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices
Via Benzinga
Topics Government
AstraZeneca Taps Gene Editing And AI Platform For Drug Discovery For Immunology Diseases
Via Benzinga
Topics Artificial Intelligence
AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy
Via Benzinga
Are Pure Play Quantum Computing Stocks a Buy in October?
Via The Motley Fool
DATROWAY® (datopotamab deruxtecan-dlnk) improved OS and PFS in TROPION-Breast02
From AstraZeneca
Via Business Wire
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape
Via MarketMinute
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
Via Benzinga
Investing in These 3 Quantum Computing Stocks Could Be a Once-in-a-Lifetime Opportunity
Via The Motley Fool
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
Via MarketMinute
Topics Economy Intellectual Property Stocks
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
Via The Motley Fool
Topics Government World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Via Benzinga
Topics ETFs
AstraZeneca's Strategic Listing Harmonization: A Unified Global Platform for Growth
Via MarketMinute
Topics Economy
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
Via Investor's Business Daily
AstraZeneca Moves From ADRs To NYSE Listing
Via Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated highly statistically significant and clinically meaningful improvement in invasive disease-free survival vs. T-DM1 in DESTINY-Breast05 Phase III trial
From AstraZeneca
Via Business Wire
3 Magnificent Stocks Under $100 to Buy Right Now
Via The Motley Fool
Your AstraZeneca Medicine Could Be Cheaper As Much As 70%
Via Benzinga
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
From AstraZeneca
Via Business Wire
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the Nasdaq Stock Market
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 85.87
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 10/08/25 11:31 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.